| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |